Diabetes Metab J.  2013 Jun;37(3):212-213. 10.4093/dmj.2013.37.3.212.

Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J 2013;37:117-24)

• Lee BW

• KMID: 2174296
• DOI: http://doi.org/10.4093/dmj.2013.37.3.212

Abstract

No abstract available.

MeSH Terms

Biphasic Insulins
Biphasic Insulins

Reference

1. Tibaldi JM. Intensifying insulin therapy in type 2 diabetes mellitus: dosing options for insulin analogue premixes. Clin Ther. 2011; 33:1630–1642.

2. Tibaldi J, Rakel RE. Why, when and how to initiate insulin therapy in patients with type 2 diabetes. Int J Clin Pract. 2007; 61:633–644.

3. Unnikrishnan AG, Tibaldi J, Hadley-Brown M, Krentz AJ, Ligthelm R, Damci T, Gumprecht J, Gero L, Mu Y, Raz I. Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. Int J Clin Pract. 2009; 63:1571–1577.

4. Song KH, Kim JM, Noh JH, Park Y, Son HS, Min KW, Ko KS. Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study. Diabetes Metab J. 2013; 37:117–124.

5. Yoo HJ, Park KY, Park KS, Ahn KJ, Min KW, Park JH, Chang SA, Cha BS, Kim DJ, Kim YS, Oh TK, Chon S, Nam-Goong IS, Kim MJ, Kim HS, Choi YS, Ahn YH, Lee SR, Baik SH. Safety and efficacy of modern insulin products. Diabetes Metab J. 2013; 37:181–189.

6. Yoshioka N, Kurihara Y, Manda N, Komori K, Kato M, Kijima H, Wada N, Yanagisawa K, Aoki S, Ono Y, Koike T. Step-up therapy with biphasic insulin aspart-70/30: Sapporo 1-2-3 study. Diabetes Res Clin Pract. 2009; 85:47–52.

7. Jang HC, Lee SR, Vaz JA. Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMixstudy. Diabetes Obes Metab. 2009; 11:20–26.